Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Italy Spain
  • Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Study of AZD2962 tablets alone and with other medications in patients with myelodysplastic syndromes and dysplastic chronic myelomonocytic leukemia

    Not yet recruiting

    2 1 1
    Spain
  • Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Effectiveness of Pembrolizumab, Favezelimab, and Vibostolimab for Children and Young Adults with Blood Cancers or Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Denmark
  • Study of Fibrinogen Treatment for Bleeding in Patients with Blood Cancer and Low Platelet Count Who Do Not Respond to Platelet Transfusions

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of ICT01 and Pembrolizumab for Patients with Advanced-Stage, Relapsed/Refractory Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Belgium France Germany Spain
  • Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Czechia Denmark Greece Hungary Poland Spain +1
  • Study of Elraglusib Alone or with Chemotherapy for Patients with Refractory Blood Cancers or Solid Tumors

    Not recruiting

    2 1 1 1
    Belgium France Portugal Spain
  • Study of Tislelizumab, Pamiparib, and Ociperlimab in Patients with Advanced Solid Tumors and Blood Cancers

    Not recruiting

    3 1 1
    France Italy Poland